Is Ignite International Brands Ltd (BILZF) a bad choice for drug makers
Ignite International Brands Ltd (BILZF) is at the top of the industry for drug manufacturers – specialties and generics according to Investors Observer. BILZF received an overall rating of 46, which means it scores over 46% of all stocks. Ignite International Brands Ltd also achieved a score of 87 in the Drug Manufacturers Industry – Specialty and Generics, which places it above 87% of the Inventories of Drug Manufacturers – Specialties and Generics. Drug Manufacturers – Specialties and Generics are ranked 143rd out of 148 industries.
What do these notes mean?
Analyzing inventory can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. Investors Observer ranks stocks according to eight different measures. We rank most of our scores in percentiles to make it easier for investors to understand. A score of 46 means the stock is more attractive than 46% of the stock. This ranking system incorporates many factors that analysts use to compare stocks in more detail. This allows you to find the best stocks available in any industry with relative ease. These percentile scores using both fundamental and technical analysis provide investors with an easy way to visualize the attractiveness of specific stocks. The stocks with the highest scores have the best valuations by analysts working on Wall Street.
What is happening with Ignite International Brands Ltd’s inventory today?
Ignite International Brands Ltd (BILZF) stock is trading at $ 1.04 on Wednesday, December 15 at 12:55 p.m., a decrease of – $ 0.01 or -0.95% from the previous closing price of 1 , $ 05. The volume today is above average. So far, 210,601 shares have been traded for an average volume of 20,843 shares. The stock has traded between $ 1.03 and $ 1.05 so far today. Click here for the full inventory report for Ignite International Brands Ltd. inventory.
Comments are closed.